Marion Michaelis

FDA investigator

Appears on 5 documents from 2016 to 2018, most often at sites in Japan. Most often cites control of microbiological contamination (21 CFR 211.113).

5
Documents on file
7.2
Observations per 483
2016
First seen
2018
Most recent

What they cite most

From 35 observations

Activity by year

2016: 2, 2017: 2, 2018: 1

Where

Japan 2 · Israel 1 · Italy 1 · South Korea 1

Is Marion Michaelis coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 TOYOBO CO., LTD.Jan 23, 2018 · Otsu, Japan
483 Rafa Laboratories Ltd.Nov 13, 2017 · Jerusalem, Israel
483 Chugai Pharma Manufacturing Co., LtdSep 1, 2017 · Utsunomiya, Japan
483 Patheon Italia S.p.ASep 7, 2016 · Ferentino, Italy
483 Samsung Biologics Co., Ltd.Jun 22, 2016 · Incheon, South Korea

About this profile

What does Marion Michaelis inspect?

Marion Michaelis appears on 5 documents on file covering 5 sites, most often in Japan.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Marion Michaelis is dated Jan 23, 2018.